Americans Turning to GLP-1 Medications in Droves for Weight Loss: A Surprising Shift in Dietary Habits A groundbreaking Gallup survey reveals a staggering surge in the number of Americans relying on GLP-1 medications for weight loss, with a record 11% of the population now taking these prescription drugs. This significant increase marks a substantial shift in the country's approach to weight management, with the number more than tripling since 2024. The rapid adoption of GLP-1 medications, which work by mimicking a natural hormone to suppress appetite and boost metabolism, suggests a growing reliance on pharmaceutical solutions to combat the nation's obesity epidemic. As the weight loss industry continues to evolve, this trend raises important questions about the long-term implications of relying on medication to achieve and maintain a healthy weight.
A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. According to the poll, 11 percent of Americans currently take a GLP-1 medication for weight loss, compared to just 3 percent in 2024. In addition, 15 percent...
